ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Kiniksa Pharmaceuticals International, Plc

Kiniksa Pharmaceuticals International, Plc is an active company incorporated on 9 April 2024 with the registered office located in London, Greater London. Kiniksa Pharmaceuticals International, Plc was registered 1 year 9 months ago.
Status
Active
Active since incorporation
Company No
15630565
Public limited company
Age
1 year 9 months
Incorporated 9 April 2024
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 8 April 2025 (9 months ago)
Next confirmation dated 8 April 2026
Due by 22 April 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 9 Apr31 Dec 2024 (8 months)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 June 2026 (5 months remaining)
Contact
Address
105 Piccadilly
Second Floor
London
W1J 7NJ
England
Address changed on 3 Dec 2025 (1 month ago)
Previous address was 105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ England
Telephone
Unreported
Email
Unreported
People
Officers
11
Shareholders
4
Controllers (PSC)
2
PSC • Director • American • Lives in United States • Born in Jul 1969
Director • American • Lives in United States • Born in Sep 1970
Director • American • Lives in United States • Born in May 1957
Director • American • Lives in United States • Born in Mar 1969
Director • American • Lives in United States • Born in Jan 1956
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Financials
Net Assets, Total Assets & Total Liabilities (2023–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£146.62M
Increased by £61.88M (+73%)
Turnover
£338.02M
Increased by £125.89M (+59%)
Employees
Unreported
Same as previous period
Total Assets
£463.66M
Increased by £50.54M (+12%)
Total Liabilities
-£113.5M
Increased by £44.84M (+65%)
Net Assets
£350.16M
Increased by £5.7M (+2%)
Debt Ratio (%)
24%
Increased by 7.86% (+47%)
Latest Activity
Registered Address Changed
1 Month Ago on 3 Dec 2025
Registered Address Changed
2 Months Ago on 4 Nov 2025
Registered Address Changed
2 Months Ago on 4 Nov 2025
Mr. Douglas Barry Appointed
4 Months Ago on 18 Sep 2025
Madelyn Zeylikman Resigned
4 Months Ago on 18 Sep 2025
Shares Cancelled
6 Months Ago on 22 Jul 2025
Shares Cancelled
6 Months Ago on 18 Jul 2025
Baker Bros. Advisors Lp (PSC) Resigned
6 Months Ago on 1 Jul 2025
Full Accounts Submitted
7 Months Ago on 11 Jun 2025
Felix Baker (PSC) Appointed
1 Year 7 Months Ago on 27 Jun 2024
Get Credit Report
Discover Kiniksa Pharmaceuticals International, Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 31 December 2025
Submitted on 19 Jan 2026
Statement of capital following an allotment of shares on 30 November 2025
Submitted on 16 Dec 2025
Registered office address changed from 105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ England to 105 Piccadilly Second Floor London W1J 7NJ on 3 December 2025
Submitted on 3 Dec 2025
Statement of capital following an allotment of shares on 31 October 2025
Submitted on 3 Dec 2025
Registered office address changed from 105 Piccadilly 105 Piccadilly London W1J 7NJ England to 105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ on 4 November 2025
Submitted on 4 Nov 2025
Registered office address changed from Third Floor 23 Old Bond Street London W1S 4PZ United Kingdom to 105 Piccadilly 105 Piccadilly London W1J 7NJ on 4 November 2025
Submitted on 4 Nov 2025
Statement of capital following an allotment of shares on 30 September 2025
Submitted on 10 Oct 2025
Appointment of Mr. Douglas Barry as a secretary on 18 September 2025
Submitted on 22 Sep 2025
Termination of appointment of Madelyn Zeylikman as a secretary on 18 September 2025
Submitted on 22 Sep 2025
Statement of capital following an allotment of shares on 31 August 2025
Submitted on 10 Sep 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year